These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16820257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
    Eker SS, Kirli S, Akkaya C, Cangur S, Sarandol A.
    World J Biol Psychiatry; 2009; 10(4 Pt 2):400-8. PubMed ID: 19670086
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
    Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M, Martin AJ, Lam W, Burt T.
    J Clin Psychiatry; 2005 Oct; 66(10):1312-20. PubMed ID: 16259546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP, Søgaard J, Roponen P, Behnke K.
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.
    Gibiino S, Marsano A, Serretti A.
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):1-8. PubMed ID: 23953038
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [Abstract] [Full Text] [Related]

  • 19. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [Abstract] [Full Text] [Related]

  • 20. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR, Arikian SR, Casciano J, Doyle JJ.
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.